HPV vaccine

Poliovirus Vaccine OPV

Rotavirus Vaccine GSK

Influenza vaccine GSK

Influenza Vaccine CSL

Flu Season's Vaccine Approved

TUESDAY, Aug. 14 -- The 2012-13 flu vaccine has been approved by the U.S. Food and Drug Administration. Six companies will produce the vaccine, the agency said in a news release. The vaccine reflects...

Novel Vaccine Combinations: towards and HIV vaccine

Novel Vaccine Combinations: towards and HIV vaccine Novel vaccine combinations•    Results and implications of proof-of-concept study testing MVA, Ad26, and Ad35 vector-based vaccines...

Progress and pitfalls in Shigella vaccine research

Shigella infection continues to have a high disease burden worldwide, especially in young children in developing countries. Here, the latest progress in Shigella vaccine research is reviewed—includi...

SLU study to use various assays for new TB vaccine development

A pilot study at Saint Louis University Center for Vaccine Development could shape the future of tuberculosis vaccine research by developing tests to identify the most promising vaccine candidates to...

GSK’s Pandemic Vaccine Will Test Swine-To-Bird Approval Transmission

FDA agreed to infer GSK’s H5N1 vaccine’s effectiveness from the effectiveness of the adjuvanted H1N1 vaccine; agency’s Vaccines and Related Biological Products Advisory Committee will weigh in â...

FDA Denies Approval For Glaxo Bird Flu Vaccine

Just weeks after questions were raised about a GlaxoSmithKline flu vaccine and its links to narcolepsy, the FDA has issued a complete response letter for a newer vaccine that contains the same superch...

Dengue Vaccine Initiative welcomes latest progress in vaccine development

(Sabin Vaccine Institute) Today, the Dengue Vaccine Initiative welcomed new clinical trial results that reveal progress in developing the first-ever dengue vaccine. In a publication in the Lancet, pha...

Custom Vaccine Targets Cancer

University of Pennsylvania researchers have created a custom vaccine for ovarian cancer patients out of their own tumor cells, helping prevent a resurgence of the deadly disease. The new vaccine is de...

A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination.

Preparation for an H5N1 influenza pandemic in humans could include priming the population in the pre-pandemic period with a vaccine produced from an existing H5N1 vaccine strain, with the possibility...

HPV vaccine for adolescent males: Acceptability to parents post-vaccine licensure.

We examined mothers' willingness to get their adolescent sons HPV vaccine. In December 2009, 2 months after approval of HPV vaccine for males, we surveyed a national sample of mothers with sons aged 9...

Efficacy of a single dose hepatitis B depot vaccine.

A single dose formulation of a novel hepatitis B vaccine, consisting of an adjuvant emulsion of liposomes in oil was produced at a manufacturing scale and delivered to rabbits. This single dose vaccin...

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok(®) trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age.

Alternative methods for influenza vaccine production are needed to ensure adequate supplies.

Hospital-based surveillance of rotavirus gastroenteritis in the era of limited vaccine uptake through the private sector.

To investigate possible impact of limited vaccine uptake by the private sector since 2007, a prospective observational study included all children